Protagonist Therapeutics, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Protagonist Therapeutics, Inc has filed 682 SEC EDGAR filings since 28 Sep 2006

SEC filing history

Showing 626-650 of 681 matching filings.

Per page
25
Current page
26
4

FORM 4 SUBMISSION

Filing date
13 Oct 2016
Reporting date
11 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Oct 2016
Reporting date
11 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Oct 2016
Reporting date
11 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89601

SC 13G filing

Filing date
11 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
28 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89601

SCHEDULE 13G

Filing date
12 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89601

SCHEDULE 13D 8-26-16

Filing date
26 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89601

SC 13G

Filing date
25 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89601

ADAGE CAPITAL PARTNERS GP, L.L.C.

Filing date
19 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89601

SC 13G filing

Filing date
19 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
16 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-213120

FORM S-8

Filing date
15 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-212476

FILED PURSUANT TO RULE 424(B)(4)

Filing date
12 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-212476

CT ORDER filing

Filing date
11 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .